Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma

[1] Oliveira IS(2017)Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management Abdominal Radiology 42 1637-1649

[2] Kilcoyne A(2016)Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management Cancer letters 379 198-205

[3] Everett JM(2009)The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival Annals of Surgical Oncology 16 3048-3056

[4] Mino-Kenudson M(2010)Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma Seminars in oncology 37 110-117

[5] Harisinghani MG(2017)Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approaches Surgical oncology 26 146-152

[6] Ganesan K(2008)Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma International Journal of Radiation Oncology, Biology, Physics 72 1495-1501

[7] Zhang H(2012)Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection Strahlentherapie und Onkologie 188 795-801

[8] Yang T(2016)Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis Journal of Clinical Oncology 34 219-226

[9] Wu M(2017)External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence Br J Radiol 90 20170061-468

[10] Shen F(2016)Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Journal of Clinical Oncology 34 460-629

[1] Oliveira IS(2017)Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management Abdominal Radiology 42 1637-1649

[2] Kilcoyne A(2016)Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management Cancer letters 379 198-205

[3] Everett JM(2009)The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival Annals of Surgical Oncology 16 3048-3056

[4] Mino-Kenudson M(2010)Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma Seminars in oncology 37 110-117

[5] Harisinghani MG(2017)Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approaches Surgical oncology 26 146-152

[6] Ganesan K(2008)Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma International Journal of Radiation Oncology, Biology, Physics 72 1495-1501

[7] Zhang H(2012)Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection Strahlentherapie und Onkologie 188 795-801

[8] Yang T(2016)Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis Journal of Clinical Oncology 34 219-226

[9] Wu M(2017)External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence Br J Radiol 90 20170061-468

[10] Shen F(2016)Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Journal of Clinical Oncology 34 460-629